Global Complement Inhibitors Market is driven by rising autoimmune disease prevalence
Complement inhibitors are specialized biologic therapies designed to regulate the complement system, a critical component of innate immunity that, when overactivated, contributes to a range of autoimmune and rare disorders. These inhibitors—such as monoclonal antibodies targeting C5 and small molecules interfering with complement activation—offer precise modulation, reducing...
0 Commentaires 0 Parts 122 Vue 0 Aperçu